Hormonal effects on the mammary gland of postmenopausal nonhuman primates.
Macaques are Old World anthropoid primates with a high degree of genetic identity to human beings and striking similarities in breast development, reproductive endocrinology, and menstrual cycle characteristics. These animals share critical pathways of hormone metabolism with humans, to a degree that is distinct from rodent models. Macaques also express estrogen receptors alpha and beta, progesterone receptors, and androgen receptors in the normal breast in patterns similar to those described for women. Spontaneously occurring hormone-dependent breast cancers occur in macaques at a similar prevalence to lower-risk populations of women, and these neoplasms exhibit similar growth patterns and key molecular changes seen in human lesions. These similarities lend support to a biomarker approach for modeling breast cancer risk. Estrogen+progestogen treatment of postmenopausal animals produces a proliferative response in the normal breast epithelium which reflects the breast cancer promoting effects of continuous combined hormone replacement therapy. Studies of novel agents such as tibolone, selective estrogen receptor modulators, and alternative progestogens in macaques have also helped to identify hormonal therapies with a more acceptable balance of benefit to risk. Future studies of novel selective estrogens, androgens, and dietary estrogens in the macaque model will further contribute to our understanding of breast cancer risk and prevention.
Cline
J Mark
JM
Department of Pathology, Section on Comparative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1040, USA. jmcline@wfubmc.edu
Wood
Charles E
CE
D000818:Animals; D004195:Disease Models, Animal; D004967:Estrogens / Q000633:toxicity*; D005260:Female; D013006:Growth Hormone / Q000097:blood; D006965:Hyperplasia; D008251:Macaca; D008321:Mammary Glands, Animal / Q000166:cytology / Q000187:drug effects* / Q000254:growth & development / Q000473:pathology; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced*; D009652:Norpregnenes / Q000633:toxicity; D048789:Phytoestrogens / Q000494:pharmacology; D017698:Postmenopause; D011374:Progesterone / Q000633:toxicity*; D011388:Prolactin / Q000097:blood; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis
D004967:Estrogens; D009652:Norpregnenes; D048789:Phytoestrogens; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D011374:Progesterone; D011388:Prolactin; D013006:Growth Hormone; C027385:tibolone